Randomized trial · people

Teriparatide: more bony union at 6 months than zoledronate after PLIF

Checked against the paper Randomized trialPublished by PepVault

The takeaway

In this trial, teriparatide sped early bone healing and raised bone density more than zoledronate after lumbar fusion, but final fusion rates ended up similar.

Kind
Randomized trial
Studied in
People
Number studied
77
Published
2022
Journal
World Neurosurg

What they tested

The team tested whether teriparatide or zoledronate works better for spinal fusion in women with osteoporosis after posterior lumbar interbody fusion (PLIF), a type of lower-back fusion surgery.

How the study was done

A randomized trial in postmenopausal women with osteoporosis who had PLIF for degenerative spondylolisthesis, a slipped vertebra from wear and tear. They were assigned to teriparatide or zoledronate, and 77 completed 2 years of follow-up (36 teriparatide, 41 zoledronate).

A woman in glasses at a kitchen table with a laptop, a mug and her phone

PepVault for iPhone

Taking teriparatide? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

What they found

Bony union, where the fused bones knit together, was reached more often with teriparatide than with zoledronate at 6 months (P < 0.05), but the overall union rate was similar between groups. Hardware-related problems (a combined count of fractures in the next vertebra, hardware failure and fusion failure) were similar: 13.9% with teriparatide vs 22.0% with zoledronate. Bone mineral density (BMD, a measure of bone strength) rose in both groups, with a bigger gain in the teriparatide group at 12 months. Scores on the Oswestry disability index (ODI, a back-pain disability score where lower is better) fell in both groups and were lower with teriparatide at 12 months.

What it doesn’t show

This was a small trial of 77 women, all postmenopausal with osteoporosis and one kind of spine condition, so it may not apply to men or other surgeries. It compared two active drugs without a placebo group, and the counts cover only the women who finished the 2-year follow-up.

The paper

Xiong et al. Effect of Teriparatide Versus Zoledronate on Posterior Lumbar Interbody Fusion in Postmenopausal Women with Osteoporosis. World Neurosurg. 2022.

The compound

More studies on Teriparatide

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.

Track it in the app

PepVault for iPhone

Taking teriparatide? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo